Sumitomo Chemical India Ltd
Sumitomo Chemical India Ltd. (SCIL) is one of the leading players in the industry which has a balanced portfolio of technical as well as formulation products along with backward integration for some products. The Company is known for domestic marketing of proprietary products of its Japanese parent -Sumitomo Chemical Company Limited in agrochemicals, animal nutrition, and environmental health business segments. With the integration of Excel Crop Care Limited, the Company now has a strong portfolio of generics in addition to specialty products and a strong combined marketing network. With this integration, the Company has moved up several notches in the pecking order of the Indian crop protection industry. SCIL has also marked its presence in Africa and several other geographies of the world.[1] [2]
- Market Cap ₹ 20,123 Cr.
- Current Price ₹ 403
- High / Low ₹ 455 / 336
- Stock P/E 60.4
- Book Value ₹ 50.6
- Dividend Yield 0.30 %
- ROCE 30.2 %
- ROE 23.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 28.3% CAGR over last 5 years
Cons
- Stock is trading at 7.97 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
451 | 495 | 635 | 671 | 724 | 799 | 1,911 | 2,223 | 2,423 | 2,643 | 3,060 | 3,511 | 2,820 | |
463 | 484 | 587 | 614 | 635 | 698 | 1,691 | 1,932 | 2,088 | 2,155 | 2,458 | 2,843 | 2,404 | |
Operating Profit | -12 | 10 | 48 | 57 | 89 | 101 | 219 | 291 | 335 | 488 | 603 | 668 | 416 |
OPM % | -3% | 2% | 8% | 8% | 12% | 13% | 11% | 13% | 14% | 18% | 20% | 19% | 15% |
1 | 3 | 3 | 8 | 26 | 10 | 31 | -0 | -20 | 19 | 36 | 45 | 86 | |
Interest | 0 | 0 | 2 | 1 | 1 | 1 | 5 | 5 | 7 | 7 | 8 | 6 | 5 |
Depreciation | 0 | 0 | 6 | 6 | 7 | 7 | 24 | 28 | 41 | 47 | 45 | 52 | 59 |
Profit before tax | -11 | 13 | 43 | 58 | 107 | 103 | 221 | 258 | 267 | 453 | 586 | 655 | 437 |
Tax % | 0% | 0% | 23% | 40% | 40% | 40% | 34% | 35% | 23% | 24% | 26% | 23% | |
-11 | 13 | 33 | 35 | 65 | 62 | 145 | 167 | 206 | 345 | 434 | 503 | 333 | |
EPS in Rs | 4.12 | 6.92 | 8.69 | 10.09 | 6.67 | ||||||||
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 38% | 18% | 12% | 12% | 12% |
Compounded Sales Growth | |
---|---|
10 Years: | 22% |
5 Years: | 13% |
3 Years: | 13% |
TTM: | -20% |
Compounded Profit Growth | |
---|---|
10 Years: | 44% |
5 Years: | 28% |
3 Years: | 31% |
TTM: | -34% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 11% |
1 Year: | -2% |
Return on Equity | |
---|---|
10 Years: | 22% |
5 Years: | 23% |
3 Years: | 24% |
Last Year: | 23% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 233 | 233 | 233 | 233 | 233 | 275 | 275 | 275 | 499 | 499 | 499 | 499 | 499 |
Reserves | -82 | -70 | -36 | -2 | 63 | 360 | 665 | 761 | 710 | 1,029 | 1,425 | 1,881 | 2,025 |
0 | 1 | 0 | 0 | 0 | 0 | 10 | 20 | 36 | 33 | 38 | 34 | 29 | |
208 | 202 | 243 | 234 | 280 | 288 | 695 | 791 | 848 | 1,097 | 1,047 | 955 | 974 | |
Total Liabilities | 359 | 367 | 440 | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,369 | 3,528 |
53 | 48 | 47 | 51 | 52 | 53 | 267 | 279 | 319 | 309 | 390 | 430 | 501 | |
CWIP | 0 | 0 | 0 | 0 | 1 | 7 | 9 | 8 | 10 | 14 | 35 | 71 | 23 |
Investments | 0 | 0 | 0 | 0 | 0 | 277 | 2 | 1 | 87 | 291 | 357 | 239 | 587 |
306 | 319 | 393 | 415 | 523 | 585 | 1,367 | 1,558 | 1,676 | 2,043 | 2,227 | 2,628 | 2,416 | |
Total Assets | 359 | 367 | 440 | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,369 | 3,528 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
75 | -16 | 20 | 4 | 52 | -21 | 49 | 75 | 222 | 424 | 223 | 389 | |
-2 | -1 | -8 | -8 | -5 | -289 | -40 | -35 | -118 | -282 | -281 | -327 | |
-49 | 0 | -1 | 0 | -0 | 276 | 7 | -65 | -61 | -47 | -63 | -73 | |
Net Cash Flow | 24 | -17 | 11 | -4 | 47 | -34 | 16 | -26 | 43 | 95 | -120 | -10 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 105 | 96 | 90 | 83 | 92 | 101 | 105 | 110 | 128 | 117 | 101 | 98 |
Inventory Days | 125 | 135 | 169 | 191 | 202 | 193 | 133 | 185 | 198 | 157 | ||
Days Payable | 134 | 109 | 132 | 115 | 176 | 136 | 112 | 145 | 110 | 87 | ||
Cash Conversion Cycle | 105 | 96 | 81 | 109 | 130 | 177 | 131 | 167 | 150 | 157 | 189 | 168 |
Working Capital Days | 42 | 62 | 58 | 69 | 79 | 113 | 115 | 119 | 111 | 97 | 128 | 138 |
ROCE % | -8% | 8% | 25% | 27% | 41% | 22% | 29% | 27% | 26% | 33% | 34% | 30% |
Documents
Announcements
- Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015. 30 Apr
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 26 Apr
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 22 Apr
- PCS Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015. 18 Apr
- Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015. 15 Apr
Annual reports
Concalls
-
Feb 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptNotesPPT
-
Aug 2022TranscriptNotesPPT
-
Jun 2022Transcript PPT REC
-
Feb 2022TranscriptNotesPPT
-
Nov 2021Transcript PPT
-
Aug 2021TranscriptNotesPPT
-
Jun 2021Transcript PPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
-
Jun 2020TranscriptNotesPPT
-
Feb 2020TranscriptNotesPPT
Products
The Company has a presence in all the product segments - insecticides, weedicides, fungicides, fumigants and rodenticides, plant growth nutrition products, bio-rationals, and plant growth regulators. The Company is known for domestic marketing of proprietary products of its Japanese parent – Sumitomo Chemical Company, Limited in agrochemicals, animal nutrition, and environmental health business segments. [1]
The products comprise conventional chemistry sourced from the parent company, SCC, and biological products sourced from a USA-based subsidiary, Valent Biosciences LLC, a leader in producing a range of naturally occurring, environmentally compatible pesticides and plant growth regulators, for over 40 years. [2]